drugset / Trial / NCT05604690
Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is a Phase I, first-in-human (FIH), double-blind, placebo- and OMV-controlled study of Avacc 10 in healthy adult male and female subjects to investigate the safety, tolerability, and immunogenicity of intranasally administered Avacc 10.
Timeline
- Start
- 2022-11-03
- Primary completion
- 2023-08-09
- Completion
- 2024-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avacc 10 | Vaccine | — | Intranasal |
| Subject | Outer Membrane Vesicles (OMV) | Unknown | — | Intranasal |